Calciphylaxis is an ischemic vasculopathy with high morbidity and mortality. Early and accurate diagnosis is critical to management of calciphylaxis, and clinical mimickers may contribute to delayed or misdiagnosis.To assess …
Dermatologic Infections in Cancer Patients Treated with Checkpoint Inhibitors.
The incidence of dermatologic infections in patients receiving checkpoint inhibitors (CPIs) has not been systematically described.Identify the incidence of dermatologic infections in patients who received CPIs and were evaluated by …
Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk and neck in a vehicle-controlled Phase III study.
Actinic keratoses (AK) may occur in all sun exposed skin areas. However, those occurring outside the head area are generally more resistant to treatment than those on the face.To determine …
The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study.
The burden of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid (BP) and pemphigus is yet to be evaluated.To assess the risk of COVID-19, and COVID-19-associated hospitalization and mortality …
Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis.
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Interleukin (IL)-13, a type 2 cytokine, is key in AD inflammation. Tralokinumab is a first-in-class, fully human, monoclonal antibody that specifically …
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.
Guidelines for pathologic evaluation of neoadjuvant specimens and pathologic response categories have been developed by the International Neoadjuvant Melanoma Consortium (INMC). As part of the OpACIN-neo clinical trial of neoadjuvant …